Cargando…
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
OBJECTIVE: To investigate the incidence of new onset type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors (dutasteride or finasteride) for long term treatment of benign prostatic hyperplasia. DESIGN: Population based cohort study. SETTING: UK Clinical Practice Research Datalink...
Autores principales: | Wei, Li, Lai, Edward Chia-Cheng, Kao-Yang, Yea-Huei, Walker, Brian R, MacDonald, Thomas M, Andrew, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456811/ https://www.ncbi.nlm.nih.gov/pubmed/30971393 http://dx.doi.org/10.1136/bmj.l1204 |
Ejemplares similares
-
5α-Reductase Type 1 Modulates Insulin Sensitivity in Men
por: Upreti, Rita, et al.
Publicado: (2014) -
Subcellular localization of the five members of the human steroid 5α-reductase family
por: Scaglione, Antonella, et al.
Publicado: (2017) -
Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
por: Xiao, Qingpin, et al.
Publicado: (2020) -
Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride
por: Xiao, Qingpin, et al.
Publicado: (2020) -
Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors
por: Koo, Kyo Chul, et al.
Publicado: (2013)